Persistence Market Research analyzes the global Huber Needles market over an eight-year period in a newly published report. The main objective of the report is to identify key dynamics influencing the global Huber Needles market during the forecast period (2016–2024) and provide recent updates and insights impacting the various segments of the global Huber Needles market.
The report covers the global Huber Needles market performance in terms of revenue contribution from various segments. The report includes a detailed impact analysis of key trends, drivers, restraints, and opportunities influencing the growth of the global Huber Needles market. The report begins with an overview of the Huber Needles market and the main reasons why patients worldwide are adopting this device. This section also underlines factors influencing the growth of the global Huber Needles market along with a detailing of the key market dynamics. The report also provides strategic recommendations for leading players operating in the global Huber Needles market to strengthen their footprint and ensure their business stays sustainably profitable.
The next few sections provide a detailed analysis of every segment and sub-segment of the global Huber Needles market in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractiveness index, and BPS analysis. The report further highlights the growth trends of the Huber Needles market by region and presents a market outlook for 2016–2024, showcasing key regional trends contributing to the growth of the Huber Needles market worldwide, as well as an analysis of the extent to which drivers are influencing this market in each region.
The final section of the report includes detailed company profiles with company-specific long-term and short-term strategies, key offerings, and recent developments in the global Huber Needles market. Some of the leading companies profiled in the report are Baxter International Inc., C. R. Bard, NIPRO Medical Corporation, B. Braun Medical Inc., Smiths Medical, Exel International, Inc., Vygon S.A., AngioDynamics, Inc., and Thiebaud S.A.S.
The report considers 2015 as the base year and provides data for the forecast period 2016–2024. To deduce market size, the report considers various viewpoints based on extensive primary and secondary research. The report begins by sizing the current market – a key indicator of how the market is likely to perform during the forecast period. Given the characteristics of the market, the report presents triangulated data on the basis of supply side and demand side analysis and other dynamics of the global Huber Needles market. Key indicators such as number of Huber Needles patients in each year, adoption of treatment, diagnosis rate, etc., have been considered to arrive at the indicated market numbers. Given the ever-fluctuating nature of the global economy, the report presents forecasts not only in terms of CAGR, but also analyzes the global Huber Needles market on the basis of key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities in the global Huber Needles market.
The report also analyzes the global Huber Needles market segments in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important to identify the many trends governing the global Huber Needles market. Another key feature of this report is a comprehensive analysis of the global Huber Needles market revenue forecast in terms of absolute dollar opportunity, critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global Huber Needles market. In order to understand key segments in terms of growth and performance in the global Huber Needles market, Persistence Market Research has also developed a market attractiveness index to help providers identify real market opportunities in the global Huber Needles market.
The emergence of modern healthcare has changed the entire demography of the healthcare tools market. The smallest of the apparatus required by a physician for treating a patient is evolving with time. Huber Needles is one such key component of treatment for cancer patients. These are non-corning needles used to access the port implanted in a patient’s body for long-term medications such as chemotherapy, dialysis, IV nutrition supply, and other drug delivery. The Huber Needles industry is soaring worldwide as diseases like cancer, chronic renal ailments, and obesity are on the rise; and this is further expediting the growth of the global Huber Needles market. The global Huber Needles market revenue is estimated to reach US$ 55.0 Mn by 2024, registering a CAGR of 6.3% during the forecast period (2016-2024).
A plethora of key factors is inciting the growth of the global Huber Needles market. The meteoric rise of deadly ailments such as cancer, chronic renal diseases, and obesity are creating a massive opportunity for companies operating in the global Huber Needles market. Recently laid government regulations to ensure patient safety and to minimize needle stick injuries are expected to drive the growth of the global Huber Needles market during the forecast period. Apart from this, the introduction of favorable reimbursement policies of vascular access needles is also likely to ensure a revenue surge of the global Huber Needles market in the coming years. However, a lack of product innovation, heavy price tags attached to the product, and risk of contamination might hamper the organic growth of the global Huber Needles market over the forecast period.
The global Huber Needles market is segmented on the basis of Product Type (Curved Huber Needles, Straight Huber Needles); Application Type (Dialysis, Blood Transfusions, IV Cancer Application, Lap-band Adjustments, Home Parenteral Nutrition, Others); and End User (Hospitals, Oncology Centers, Clinics, Ambulatory Surgical Centers, Home Care Settings). The Curved product type segment is expected to witness a 1.7X increase in revenue by the end of 2024 and is projected to register a CAGR of 6.5% over the forecast period – reaching a market value of US$ 44.3 Mn by the end of 2024. The Cancer Application segment is estimated to hold 40.7% market share of the global Huber Needles market by 2016 and is predicted to reach 43.4% by 2024. The revenue will soar in this segment within the forecast period as there is a substantial rise in chemotherapy patients to be treated with Huber Needles. The rise in the use of Huber Needles for blood transfusion will also escalate the growth of this segment to witness a CAGR of 6.2%. The Hospitals end user segment is likely to account for 38.3% market share of the global Huber Needles market by 2016. The Oncology Centers end user segment is estimated to be valued at US$ 8.8 Mn by 2016 and is expected to register a CAGR of 6.6%.
The global Huber Needles market is segmented into the five key regions of North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America and Europe are expected to dominate the global Huber Needles market by collectively accounting for one-third of the overall market share by the end of 2016. The Latin America and Asia Pacific markets are expected to register significant growth during the forecast period. Revenue from the Asia Pacific market is expected to register a robust CAGR of 8.1% during the forecast period.
Companies dominating the global Huber Needles market
Baxter International Inc, C.R. Bard, NIPRO Medical Corporations, B. Braun Medical Inc, Smiths Medical, Exel International, Inc., Vygon S.A., AngioDynamics, Inc., and Thiebaud S.A.S. are some of the leading companies operating in the global Huber Needles market. Top market players are constantly working to enhance their product outreach.